Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ophthalmology

  Free Subscription


Articles published in J Ocul Pharmacol Ther

Retrieve available abstracts of 118 articles:
HTML format
Text format



Single Articles


    November 2017
  1. BANTSEEV V, Erickson R, Leipold D, Amaya C, et al
    Nonclinical Safety Assessment of Anti-Factor D: Key Strategies and Challenges for the Nonclinical Development of Intravitreal Biologics.
    J Ocul Pharmacol Ther. 2017 Nov 17. doi: 10.1089/jop.2017.0063.
    PubMed     Text format     Abstract available


  2. MIOTTO S, Zemella N, Gusson E, Panozzo G, et al
    Morphologic Criteria of Lesion Activity in Neovascular Age-Related Macular Degeneration: A Consensus Article.
    J Ocul Pharmacol Ther. 2017 Nov 17. doi: 10.1089/jop.2017.0022.
    PubMed     Text format     Abstract available


  3. SUWANNOI P, Chomnawang M, Sarisuta N, Reichl S, et al
    Development of Acyclovir-Loaded Albumin Nanoparticles and Improvement of Acyclovir Permeation Across Human Corneal Epithelial T Cells.
    J Ocul Pharmacol Ther. 2017 Nov 7. doi: 10.1089/jop.2017.0057.
    PubMed     Text format     Abstract available


  4. EATON JS, Miller PE, Bentley E, Thomasy SM, et al
    Slit Lamp-Based Ocular Scoring Systems in Toxicology and Drug Development: A Literature Survey.
    J Ocul Pharmacol Ther. 2017 Nov 7. doi: 10.1089/jop.2017.0021.
    PubMed     Text format     Abstract available


  5. DI ZAZZO A, Roberti G, Mashaghi A, Abud TB, et al
    Use of Topical Cannabinomimetic Palmitoylethanolamide in Ocular Surface Disease Associated with Antiglaucoma Medications.
    J Ocul Pharmacol Ther. 2017;33:670-677.
    PubMed     Text format     Abstract available


    October 2017
  6. PAPANGKORN K, Prendergast E, Higuchi JW, Brar B, et al
    Noninvasive Ocular Drug Delivery System of Dexamethasone Sodium Phosphate in the Treatment of Experimental Uveitis Rabbit.
    J Ocul Pharmacol Ther. 2017 Oct 12. doi: 10.1089/jop.2017.0053.
    PubMed     Text format     Abstract available


  7. MOUSTAFA MT, Ramirez C, Schneider K, Atilano SR, et al
    Protective Effects of Memantine on Hydroquinone-Treated Human Retinal Pigment Epithelium Cells and Human Retinal Muller Cells.
    J Ocul Pharmacol Ther. 2017;33:610-619.
    PubMed     Text format     Abstract available


    September 2017
  8. GARWEG JG, Niderprim SA, Russ HM, Pfister IB, et al
    Comparison of Strategies of Treatment with Ranibizumab in Newly-Diagnosed Cases of Neovascular Age-Related Macular Degeneration.
    J Ocul Pharmacol Ther. 2017 Sep 27. doi: 10.1089/jop.2017.0006.
    PubMed     Text format     Abstract available


  9. LIN CJ, Chen HS, Su CW, Tien PT, et al
    The Effect of Age and Initial Central Retinal Thickness on Earlier Need of Repeat Ozurdex Treatment for Macular Edema Due to Retinal Vein Occlusion: A Retrospective Case Series.
    J Ocul Pharmacol Ther. 2017 Sep 26. doi: 10.1089/jop.2017.0070.
    PubMed     Text format     Abstract available


  10. CORCORAN P, Hollander DA, Ousler GW 3rd, Angjeli E, et al
    Dynamic Sensitivity of Corneal TRPM8 Receptors to Menthol Instillation in Dry Eye Versus Normal Subjects.
    J Ocul Pharmacol Ther. 2017.
    PubMed     Text format     Abstract available


  11. GUERRA M, Marques S, Quadrado Gil J, Campos J, et al
    Neurotrophic Keratopathy: Therapeutic Approach Using a Novel Matrix Regenerating Agent.
    J Ocul Pharmacol Ther. 2017.
    PubMed     Text format     Abstract available


    August 2017
  12. TRESE MGJ, Lewis AW, Blachley TS, Stein JD, et al
    Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource Utilization.
    J Ocul Pharmacol Ther. 2017 Aug 30. doi: 10.1089/jop.2017.0051.
    PubMed     Text format     Abstract available


  13. ZANDI S, Lereuil T, Freiberg F, Pfau M, et al
    Long-Term Intravitreal Dexamethasone Treatment in Eyes with Pretreated Chronic Diabetic Macular Edema.
    J Ocul Pharmacol Ther. 2017 Aug 24. doi: 10.1089/jop.2017.0020.
    PubMed     Text format     Abstract available


  14. FLINEY GD, Zukin LM, Hagedorn C
    Neovascular Age-Related Macular Degeneration Disease Quiescence with Visual Acuity Stability in a Subgroup of Patients Following PRN Treatment.
    J Ocul Pharmacol Ther. 2017 Aug 22. doi: 10.1089/jop.2017.0013.
    PubMed     Text format     Abstract available


  15. HE S, Stankowska DL, Ellis DZ, Krishnamoorthy RR, et al
    Targets of Neuroprotection in Glaucoma.
    J Ocul Pharmacol Ther. 2017 Aug 18. doi: 10.1089/jop.2017.0041.
    PubMed     Text format     Abstract available


  16. HAYS CL, Okafor KC, Fan S, High R, et al
    Consequences of Puberty on Efficacy of Intraocular Pressure-Lowering Drugs in Male Dutch-Belted Rabbits.
    J Ocul Pharmacol Ther. 2017 Aug 18. doi: 10.1089/jop.2016.0168.
    PubMed     Text format     Abstract available


  17. KATSANOS A, Dastiridou AI, Quaranta L, Rulli E, et al
    The Effect of Posture on Intraocular Pressure and Systemic Hemodynamic Parameters in Treated and Untreated Patients with Primary Open-Angle Glaucoma.
    J Ocul Pharmacol Ther. 2017 Aug 16. doi: 10.1089/jop.2017.0030.
    PubMed     Text format     Abstract available


  18. CAVET ME, DeCory HH
    The Role of Nitric Oxide in the Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod: Review of Nonclinical Studies.
    J Ocul Pharmacol Ther. 2017 Aug 7. doi: 10.1089/jop.2016.0188.
    PubMed     Text format     Abstract available


  19. TORIS CB, Gelfman C, Whitlock A, Sponsel WE, et al
    Making Basic Science Studies in Glaucoma More Clinically Relevant: The Need for a Consensus.
    J Ocul Pharmacol Ther. 2017 Aug 4. doi: 10.1089/jop.2017.0001.
    PubMed     Text format     Abstract available


    July 2017
  20. KIM HS, Kim TI, Kim JH, Yoon KC, et al
    Evaluation of Clinical Efficacy and Safety of a Novel Cyclosporin A Nanoemulsion in the Treatment of Dry Eye Syndrome.
    J Ocul Pharmacol Ther. 2017 Jul 31. doi: 10.1089/jop.2016.0164.
    PubMed     Text format     Abstract available


  21. CAIRNS EA, Szczesniak AM, Straiker AJ, Kulkarni PM, et al
    The In Vivo Effects of the CB1-Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice.
    J Ocul Pharmacol Ther. 2017 Jul 18. doi: 10.1089/jop.2017.0037.
    PubMed     Text format     Abstract available


  22. GANDHI JK, Roy Chowdhury U, Manzar Z, Buck J, et al
    Differential Intraocular Pressure Measurements by Tonometry and Direct Cannulation After Treatment with Soluble Adenylyl Cyclase Inhibitors.
    J Ocul Pharmacol Ther. 2017 Jul 7. doi: 10.1089/jop.2017.0027.
    PubMed     Text format     Abstract available


    June 2017
  23. VERHOEVEN RS, Garcia A, Robeson R, Gilger BC, et al
    Nonclinical Development of ENV905 (Difluprednate) Ophthalmic Implant for the Treatment of Inflammation and Pain Associated with Ocular Surgery.
    J Ocul Pharmacol Ther. 2017 Jun 26. doi: 10.1089/jop.2016.0195.
    PubMed     Text format     Abstract available


  24. PATIL R, Wang H, Sharif NA, Mitra A, et al
    Aquaporins: Novel Targets for Age-Related Ocular Disorders.
    J Ocul Pharmacol Ther. 2017 Jun 20. doi: 10.1089/jop.2017.0024.
    PubMed     Text format     Abstract available


  25. LIN CW, Sherman B, Moore LA, Laethem CL, et al
    Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma.
    J Ocul Pharmacol Ther. 2017 Jun 13. doi: 10.1089/jop.2017.0023.
    PubMed     Text format     Abstract available



  26. Retraction of: Azithromycin 1.5% Ophthalmic Solution for Blepharitis Treatment: Comparison of 14- Versus 30-Day Treatment; DOI: 10.1089/jop.2015.0099.
    J Ocul Pharmacol Ther. 2017 Jun 12. doi: 10.1089/jop.2015.0099.
    PubMed     Text format    


  27. MORI A, Yabuta C, Kishimoto Y, Kozai S, et al
    In Silico Ocular Pharmacokinetic Modeling: Delivery of Topical FK962 to Retina.
    J Ocul Pharmacol Ther. 2017 Jun 9. doi: 10.1089/jop.2016.0136.
    PubMed     Text format     Abstract available


  28. KOC M, Bostanci B, Demirel OO, Genc F, et al
    The Effect of Ascorbic Acid (Vitamin C) on Transepithelial Corneal Cross-Linking in Rabbits.
    J Ocul Pharmacol Ther. 2017 Jun 7. doi: 10.1089/jop.2017.0025.
    PubMed     Text format     Abstract available


    May 2017
  29. GARWEG JG, Gerhardt C, Kodjikian L, Pfister IB, et al
    Real-Life Experience with Aflibercept and Ranibizumab in the Treatment of Newly Diagnosed Neovascular Age-Related Macular Degeneration over 24 Months.
    J Ocul Pharmacol Ther. 2017 May 30. doi: 10.1089/jop.2017.0031.
    PubMed     Text format     Abstract available


  30. FABIANI C, Vitale A, Emmi G, Lopalco G, et al
    Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema.
    J Ocul Pharmacol Ther. 2017 May 30. doi: 10.1089/jop.2017.0034.
    PubMed     Text format     Abstract available


  31. WU YH, Wang LC, Yen SH, Yu WK, et al
    Change of Serum IgG4 in Patients with Ocular Adnexal Marginal Zone B Cell Lymphoma Associated with IgG4-Related Ophthalmic Disease After Treatment.
    J Ocul Pharmacol Ther. 2017 May 17. doi: 10.1089/jop.2016.0175.
    PubMed     Text format     Abstract available


  32. FRERE A, Caspers L, Makhoul D, Judice L, et al
    Single Dexamethasone Intravitreal Implant in the Treatment of Noninfectious Uveitis.
    J Ocul Pharmacol Ther. 2017;33:290-297.
    PubMed     Text format     Abstract available


  33. FOUSSAT A, Gregoire S, Clerget-Chossat N, Terrada C, et al
    Regulatory T Cell Therapy for Uveitis: A New Promising Challenge.
    J Ocul Pharmacol Ther. 2017;33:278-284.
    PubMed     Text format     Abstract available


  34. TERADA Y, Kamoi K, Komizo T, Miyata K, et al
    Human T Cell Leukemia Virus Type 1 and Eye Diseases.
    J Ocul Pharmacol Ther. 2017;33:216-223.
    PubMed     Text format     Abstract available


    April 2017
  35. CHO HJ, Kim JM, Kim HS, Lee DW, et al
    Effect of Epiretinal Membranes on Antivascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration.
    J Ocul Pharmacol Ther. 2017 Apr 26. doi: 10.1089/jop.2016.0178.
    PubMed     Text format     Abstract available


  36. SCHMIDL D, Werkmeister R, Kaya S, Unterhuber A, et al
    A Controlled, Randomized Double-Blind Study to Evaluate the Safety and Efficacy of Chitosan-N-Acetylcysteine for the Treatment of Dry Eye Syndrome.
    J Ocul Pharmacol Ther. 2017 Apr 25. doi: 10.1089/jop.2016.0123.
    PubMed     Text format     Abstract available


  37. ANTOUN J, Willermain F, Makhoul D, Motulsky E, et al
    Topical Ganciclovir in Cytomegalovirus Anterior Uveitis.
    J Ocul Pharmacol Ther. 2017 Apr 20. doi: 10.1089/jop.2016.0138.
    PubMed     Text format     Abstract available


  38. MOOSAJEE M, Ferguson V
    Response to Aslankurt et al. re: "Safety Profile of Stromal Hydration of Clear Corneal Incisions with Cefuroxime in the Mouse Model".
    J Ocul Pharmacol Ther. 2017 Apr 19. doi: 10.1089/jop.2017.29030.
    PubMed     Text format    


  39. ORAY M, Onal S, Uludag G, Koc Akbay A, et al
    Interferon Alpha for the Treatment of Cystoid Macular Edema Associated with Presumed Ocular Tuberculosis.
    J Ocul Pharmacol Ther. 2017 Apr 17. doi: 10.1089/jop.2016.0097.
    PubMed     Text format     Abstract available


  40. ZHANG P, Wang H, Cao H, Xu X, et al
    Insulin-Like Growth Factor Binding Protein-Related Protein 1 Inhibit Retinal Neovascularization in the Mouse Model of Oxygen-Induced Retinopathy.
    J Ocul Pharmacol Ther. 2017 Apr 12. doi: 10.1089/jop.2016.0171.
    PubMed     Text format     Abstract available


  41. GONZALES JA, Haemel A, Gross AJ, Acharya NR, et al
    Management of Uveitis and Scleritis in Necrobiotic Xanthogranuloma.
    J Ocul Pharmacol Ther. 2017 Apr 10. doi: 10.1089/jop.2016.0135.
    PubMed     Text format     Abstract available


  42. KIM JH, Chang YS, Lee DW, Kim CG, et al
    Incidence and Timing of the First Recurrence in Neovascular Age-Related Macular Degeneration: Comparison Between Ranibizumab and Aflibercept.
    J Ocul Pharmacol Ther. 2017 Apr 6. doi: 10.1089/jop.2016.0098.
    PubMed     Text format     Abstract available


  43. ELBAY A, Ozdemir H, Koytak A, Melikov A, et al
    Intravitreal Dexamethasone Implant for Treatment of Serous Macular Detachment in Central Retinal Vein Occlusion.
    J Ocul Pharmacol Ther. 2017 Apr 4. doi: 10.1089/jop.2016.0187.
    PubMed     Text format     Abstract available


  44. PERENYI K, Dienes L, Kornafeld A, Kovacs B, et al
    The Effect of Tear Supplementation with 0.15% Preservative-Free Zinc-Hyaluronate on Ocular Surface Sensations in Patients with Dry Eye.
    J Ocul Pharmacol Ther. 2017 Apr 4. doi: 10.1089/jop.2016.0194.
    PubMed     Text format     Abstract available


  45. FERNANDEZ-FERREIRO A, Santiago-Varela M, Gil-Martinez M, Gonzalez-Barcia M, et al
    In Vitro Evaluation of the Ophthalmic Toxicity Profile of Chlorhexidine and Propamidine Isethionate Eye Drops.
    J Ocul Pharmacol Ther. 2017;33:202-209.
    PubMed     Text format     Abstract available


  46. GREENE WA, Burke TA, Kaini RR, Por ED, et al
    Polarized Secretion of Matrix Metalloproteinases and Their Inhibitors by Retinal Pigment Epithelium Derived from Induced Pluripotent Stem Cells During Wound Healing.
    J Ocul Pharmacol Ther. 2017;33:132-140.
    PubMed     Text format     Abstract available


  47. RUBSAM A, Thieme CE, Schlomberg J, Winterhalter S, et al
    Therapy Rationale for Mineralocorticoid-Receptor Antagonists, Acetazolamide and a Switch of Therapy in Nonresponders in Central Serous Chorioretinopathy.
    J Ocul Pharmacol Ther. 2017;33:141-148.
    PubMed     Text format     Abstract available


    March 2017
  48. STEM MS, Todorich B, Faia LJ
    Ocular Pharmacology for Scleritis: Review of Treatment and a Practical Perspective.
    J Ocul Pharmacol Ther. 2017 Mar 29. doi: 10.1089/jop.2016.0127.
    PubMed     Text format     Abstract available


  49. PORT AD, Orlin A, Kiss S, Patel S, et al
    Cytomegalovirus Retinitis: A Review.
    J Ocul Pharmacol Ther. 2017 Mar 29. doi: 10.1089/jop.2016.0140.
    PubMed     Text format     Abstract available


  50. HORI Y, Kageyama T, Sakamoto A, Shiba T, et al
    Comparison of Short-Term Effects of Diquafosol and Rebamipide on Mucin 5AC Level on the Rabbit Ocular Surface.
    J Ocul Pharmacol Ther. 2017 Mar 27. doi: 10.1089/jop.2016.0092.
    PubMed     Text format     Abstract available


  51. SCHAAP-FOGLER M, Bahar I, Rephaeli A, Dahbash M, et al
    Effect of Histone Deacetylase Inhibitor, Butyroyloxymethyl-Diethyl Phosphate (AN-7), on Corneal Neovascularization in a Mouse Model.
    J Ocul Pharmacol Ther. 2017 Mar 24. doi: 10.1089/jop.2016.0017.
    PubMed     Text format     Abstract available


  52. SCHNABOLK G, Beon MK, Tomlinson S, Rohrer B, et al
    New Insights on Complement Inhibitor CD59 in Mouse Laser-Induced Choroidal Neovascularization: Mislocalization After Injury and Targeted Delivery for Protein Replacement.
    J Ocul Pharmacol Ther. 2017 Mar 23. doi: 10.1089/jop.2016.0101.
    PubMed     Text format     Abstract available


  53. SMITH WM
    Cyclosporine: A Historical Perspective on Its Role in the Treatment of Noninfectious Uveitis.
    J Ocul Pharmacol Ther. 2017 Mar 13. doi: 10.1089/jop.2016.0155.
    PubMed     Text format     Abstract available


  54. GERY I
    Robert Burton Nussenblatt, MD, MPH (1948-2016), Physician-Scientist, Leading Ophthalmologist and Exemplary Teacher.
    J Ocul Pharmacol Ther. 2017 Mar 7. doi: 10.1089/jop.2017.29027.
    PubMed     Text format    


  55. ASLANKURT M, Andi I, Cekic O
    Re: "Safety Profile of Stromal Hydration of Clear Corneal Incisions with Cefuroxime in the Mouse Model" by Moosajee et al. (J. Ocul. Pharmacol. Ther. 32:469-475, 2016).
    J Ocul Pharmacol Ther. 2017 Mar 6. doi: 10.1089/jop.2016.0183.
    PubMed     Text format    


  56. GOMES RL, Viana RG, Melo LA Jr, Cruz AC, et al
    Aqueous Humor Penetration and Biological Activity of Moxifloxacin 0.5% Ophthalmic Solution Alone or with Dexamethasone 0.1.
    J Ocul Pharmacol Ther. 2017;33:98-102.
    PubMed     Text format     Abstract available


    February 2017
  57. PATIL A, Majumdar S
    Echinocandins in Ocular Therapeutics.
    J Ocul Pharmacol Ther. 2017 Feb 24. doi: 10.1089/jop.2016.0186.
    PubMed     Text format     Abstract available


  58. STAHL E, Bremond-Gignac D, Landry T, Curtis M, et al
    Pharmacokinetics and Safety of Travoprost 0.004% Ophthalmic Solution Preserved with Polyquad in Pediatric Patients with Glaucoma.
    J Ocul Pharmacol Ther. 2017 Feb 24. doi: 10.1089/jop.2016.0133.
    PubMed     Text format     Abstract available


  59. KOZAK I, Shoughy SS, Stone DU
    Intravitreal Antiangiogenic Therapy of Uveitic Macular Edema: A Review.
    J Ocul Pharmacol Ther. 2017 Feb 6. doi: 10.1089/jop.2016.0118.
    PubMed     Text format     Abstract available


  60. YAMADA H, Yoneda M, Inaguma S, Gosho M, et al
    A Rho-Associated Kinase Inhibitor Protects Permeability in a Cell Culture Model of Ocular Disease, and Reduces Aqueous Flare in Anterior Uveitis.
    J Ocul Pharmacol Ther. 2017 Feb 3. doi: 10.1089/jop.2016.0085.
    PubMed     Text format     Abstract available


  61. KUO DE, Wei MM, Armbrust KR, Knickelbein JE, et al
    Gradient Boosted Decision Tree Classification of Endophthalmitis Versus Uveitis and Lymphoma from Aqueous and Vitreous IL-6 and IL-10 Levels.
    J Ocul Pharmacol Ther. 2017 Feb 3. doi: 10.1089/jop.2016.0132.
    PubMed     Text format     Abstract available


    January 2017
  62. SEIBOLD LK, DeWitt PE, Kroehl ME, Kahook MY, et al
    The 24-Hour Effects of Brinzolamide/Brimonidine Fixed Combination and Timolol on Intraocular Pressure and Ocular Perfusion Pressure.
    J Ocul Pharmacol Ther. 2017 Jan 27. doi: 10.1089/jop.2016.0141.
    PubMed     Text format     Abstract available


  63. BRANSON SV, McClafferty BR, Kurup SK
    Vitrectomy for Epiretinal Membranes and Macular Holes in Uveitis Patients.
    J Ocul Pharmacol Ther. 2017 Jan 23. doi: 10.1089/jop.2016.0142.
    PubMed     Text format     Abstract available


  64. CHEN H, Lin H, Chen W, Zhang B, et al
    Topical 0.1% Bromfenac Sodium for Intraoperative Miosis Prevention and Prostaglandin E2 Inhibition in Femtosecond Laser-Assisted Cataract Surgery.
    J Ocul Pharmacol Ther. 2017 Jan 20. doi: 10.1089/jop.2016.0114.
    PubMed     Text format     Abstract available


  65. REVIGLIO VE, Osaba M, Sambuelli G, Kuo IC, et al
    Phototoxic Effect of Topical Fluoroquinolones Administered Before Corneal Crosslinking in a Murine Model.
    J Ocul Pharmacol Ther. 2017 Jan 20. doi: 10.1089/jop.2016.0060.
    PubMed     Text format     Abstract available


  66. ROBINSON J, Okoro E, Ezuedu C, Bush L, et al
    Effects of Hydrogen Sulfide-Releasing Compounds on Aqueous Humor Outflow Facility in Porcine Ocular Anterior Segments, Ex Vivo.
    J Ocul Pharmacol Ther. 2017 Jan 18. doi: 10.1089/jop.2016.0037.
    PubMed     Text format     Abstract available


  67. LIU S, Matsuo T, Hosoya O, Uchida T, et al
    Photoelectric Dye Used for Okayama University-Type Retinal Prosthesis Reduces the Apoptosis of Photoreceptor Cells.
    J Ocul Pharmacol Ther. 2017 Jan 13. doi: 10.1089/jop.2016.0093.
    PubMed     Text format     Abstract available


  68. WANG JW, Vu C, Poloso NJ
    A Prostacyclin Analog, Cicaprost, Exhibits Potent Anti-Inflammatory Activity in Human Primary Immune Cells and a Uveitis Model.
    J Ocul Pharmacol Ther. 2017 Jan 10. doi: 10.1089/jop.2016.0167.
    PubMed     Text format     Abstract available


  69. FUCHS H, Igney F
    Binding to Ocular Albumin as a Half-Life Extension Principle for Intravitreally Injected Drugs: Evidence from Mechanistic Rat and Rabbit Studies.
    J Ocul Pharmacol Ther. 2017 Jan 5. doi: 10.1089/jop.2016.0083.
    PubMed     Text format     Abstract available


  70. BATTAGLIA PARODI M, Donati S, Semeraro F, Danzi P, et al
    Intravitreal Anti-Vascular Endothelial Growth Factor Drugs for Retinal Angiomatous Proliferation in Real-Life Practice.
    J Ocul Pharmacol Ther. 2017 Jan 3. doi: 10.1089/jop.2016.0091.
    PubMed     Text format     Abstract available


    December 2016
  71. TABUCHI N, Toshida H, Koike D, Odaka A, et al
    Effect of Retinol Palmitate on Corneal and Conjunctival Mucin Gene Expression in a Rat Dry Eye Model After Injury.
    J Ocul Pharmacol Ther. 2016 Dec 23. doi: 10.1089/jop.2015.0161.
    PubMed     Text format     Abstract available


  72. GUO J, Luo X, Liang J, Xiao M, et al
    Antiangiogenic Effects of Doxazosin on Experimental Choroidal Neovascularization in Mice.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  73. LIANG IC, Lin YR, Chien HW, Liu KR, et al
    Vision Preservation in Eyes of Polypoidal Choroidal Vasculopathy with Low-Dose Intravitreal Triamcinolone Acetonide.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  74. HERBORT CP JR, Tugal-Tutkun I, Neri P, Pavesio C, et al
    Failure to Integrate Quantitative Measurement Methods of Ocular Inflammation Hampers Clinical Practice and Trials on New Therapies for Posterior Uveitis.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  75. KOBASHI H, Kamiya K, Shimizu K
    Randomized Comparison Between Rebamipide Ophthalmic Suspension and Diquafosol Ophthalmic Solution for Dry Eye After Penetrating Keratoplasty.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  76. SUZUKI T, Yamamoto T, Torikai T, Ohashi Y, et al
    Combination Effect of Cefuroxime and Levofloxacin Against Bacteria Isolated from the Healthy Conjunctival Sac and Endophthalmitis Cases Using a Fractional Inhibitory Concentration Index.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available



  77. Correction to: Journal of Ocular Pharmacology and Therapeutics 2016;32:355-364.
    J Ocul Pharmacol Ther. 2016;32:695.
    PubMed     Text format    



  78. Correction to: Journal of Ocular Pharmacology and Therapeutics 2016;32:606-622.
    J Ocul Pharmacol Ther. 2016;32:695.
    PubMed     Text format    


    November 2016
  79. SENGUL EA, Artunay O, Turkseven Kumral E, Yenerel M, et al
    Retinal Nerve Fiber Layer Thickness Changes in Age-Related Macular Degeneration Treated with Multiple Intravitreal Ranibizumab.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  80. SENTHILKUMARI S, Sharmila R, Chidambaranathan G, Vanniarajan A, et al
    Epalrestat, an Aldose Reductase Inhibitor Prevents Glucose-Induced Toxicity in Human Retinal Pigment Epithelial Cells In Vitro.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  81. YOO R, Choi YA, Cho BJ
    Change in Central Corneal Thickness After the Discontinuation of Latanoprost in Normal Tension Glaucoma-Change in Central Corneal Thickness After Stop of Latanoprost.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  82. KANG S, Choi H, Rho CR
    Differential Effects of Bevacizumab, Ranibizumab, and Aflibercept on the Viability and Wound Healing of Corneal Epithelial Cells.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


    October 2016
  83. JENSEN RJ
    Effects of Antipsychotic Drugs Haloperidol and Clozapine on Visual Responses of Retinal Ganglion Cells in a Rat Model of Retinitis Pigmentosa.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  84. WOODWARD DF, Wenthur SL, Rudebush TL, Fan S, et al
    Prostanoid Receptor Antagonist Effects on Intraocular Pressure, Supported by Ocular Biodisposition Experiments.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  85. MANNA S, Augsburger JJ, Correa ZM, Al-Rjoub MF, et al
    Noninvasive Electroretinography Assessment of Intravitreal Sustained-Release Methotrexate Microimplants in Rabbit Eyes.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  86. YASUDA K, Motohashi R, Kotake O, Nakagawa H, et al
    Comparative Effects of Topical Diclofenac and Betamethasone on Inflammation After Vitrectomy and Cataract Surgery in Various Vitreoretinal Diseases.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  87. BECKEL JM, Lu W, Civan MM, Mitchell CH, et al
    Treatment of Retinal Disorders with Purinergic Drugs: Beyond Receptors.
    J Ocul Pharmacol Ther. 2016;32:488-489.
    PubMed     Text format    


    September 2016
  88. MINNS MS, Trinkaus-Randall V
    Purinergic Signaling in Corneal Wound Healing: A Tale of 2 Receptors.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  89. REED K, Li A, Wilson B, Assamoi T, et al
    Enhancement of Ocular In Situ Gelling Properties of Low Acyl Gellan Gum by Use of Ion Exchange.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


    August 2016
  90. JACOBSON KA, Civan MM
    Ocular Purine Receptors as Drug Targets in the Eye.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  91. POR ED, Greene WA, Burke TA, Wang HC, et al
    Trichostatin A Inhibits Retinal Pigmented Epithelium Activation in an In Vitro Model of Proliferative Vitreoretinopathy.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  92. GARWEG JG, Baglivo E, Freiberg FJ, Pfau M, et al
    Response of Postoperative and Chronic Uveitic Cystoid Macular Edema to a Dexamethasone-Based Intravitreal Implant (Ozurdex).
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  93. KIM JH, Chang YS, Kim JW, Kim CG, et al
    Long-Term Outcome and Recurrence of Idiopathic Choroidal Neovascularization Treated with Intravitreal Bevacizumab.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


    July 2016
  94. ISOBE T, Kasai T, Kawai H
    Ocular Penetration and Pharmacokinetics of Ripasudil Following Topical Administration to Rabbits.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  95. BUI DK, Carvounis PE
    Favorable Outcomes of Filamentous Fungal Endophthalmitis Following Aggressive Management.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  96. HUANG JM, Pansick AD, Blomquist PH
    Use of Intravenous Vancomycin and Cefepime in Preventing Endophthalmitis After Open Globe Injury.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  97. SHIN KH, Kim JH, Cho SW, Lee TG, et al
    Efficacy of Intravitreal Bevacizumab for Recurrent Central Serous Chorioretinopathy in Patients Who Had Previously Responded Well to the Same Therapy.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  98. GARAY-ARAMBURU G, Gomez-Moreno A
    Response #2 to Immediate Intraocular Pressure Tendency Following Intravitreal Delivery of Dexamethasone Implant; Alagoz et al. J. Ocul. Pharmacol. Ther. 32:44-49, 2016.
    J Ocul Pharmacol Ther. 2016;32:344-5.
    PubMed     Text format    


    June 2016
  99. GERBER WM, Meyer D, Smit DP
    Ocular and Cerebrospinal Fluid Penetration of Antiretroviral Agents.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  100. MOOSAJEE M, Tracey-White D, Harbottle RP, Ferguson V, et al
    Safety Profile of Stromal Hydration of Clear Corneal Incisions with Cefuroxime in the Mouse Model.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  101. JEON HS, Hyon JY
    The Efficacy of Diquafosol Ophthalmic Solution in Non-Sjogren and Sjogren Syndrome Dry Eye Patients Unresponsive to Artificial Tear.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  102. SAKATA R, Sakisaka T, Matsuo H, Miyata K, et al
    Effect of Travoprost and Nonsteroidal Anti-Inflammatory Drug on Diurnal Intraocular Pressure in Normal Subjects with Low-Teen Baseline Intraocular Pressure.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  103. QUERQUES G, Darvizeh F, Querques L, Capuano V, et al
    Assessment of the Real-Life Usage of Intravitreal Dexamethasone Implant in the Treatment of Chronic Diabetic Macular Edema in France.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  104. TORIS CB, McLaughlin MA, Dworak DP, Fan S, et al
    Effects of Rho Kinase Inhibitors on Intraocular Pressure and Aqueous Humor Dynamics in Nonhuman Primates and Rabbits.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  105. MAH FS
    Effect on Gel Formation Time of Adding Topical Ophthalmic Medications to ReSure Sealant, an In Situ Hydrogel.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


    May 2016
  106. KIKUSHIMA W, Sakurada Y, Sugiyama A, Tanabe N, et al
    Factors Predictive of Visual Outcome 1 Year After Intravitreal Aflibercept Injection for Typical Neovascular Age-Related Macular Degeneration.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  107. JOSHI R, Mankowski W, Winter M, Saini JS, et al
    Automated Measurement of Cobblestone Morphology for Characterizing Stem Cell Derived Retinal Pigment Epithelial Cell Cultures.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  108. YUN H, Zhou Y, Wills A, Du Y, et al
    Stem Cells in the Trabecular Meshwork for Regulating Intraocular Pressure.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  109. LEACH LL, Croze RH, Hu Q, Nadar VP, et al
    Induced Pluripotent Stem Cell-Derived Retinal Pigmented Epithelium: A Comparative Study Between Cell Lines and Differentiation Methods.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


    April 2016
  110. NOVACK GD
    Eyes on New Product Development.
    J Ocul Pharmacol Ther. 2016;32:133-4.
    PubMed     Text format    


  111. BANSAL P, Garg S, Sharma Y, Venkatesh P, et al
    Posterior Segment Drug Delivery Devices: Current and Novel Therapies in Development.
    J Ocul Pharmacol Ther. 2016;32:135-44.
    PubMed     Text format     Abstract available


    March 2016
  112. NOVACK GD
    Eyes on New Product Development.
    J Ocul Pharmacol Ther. 2016;32:65-6.
    PubMed     Text format    


    January 2016
  113. NOVACK GD
    Eyes on New Product Development.
    J Ocul Pharmacol Ther. 2016;32:1-2.
    PubMed     Text format    


  114. MCKAY BS, Schwartz SG
    Pigmentation and Macular Degeneration: Is There a Role for GPR143?
    J Ocul Pharmacol Ther. 2016;32:3-4.
    PubMed     Text format    


  115. CUCHACOVICH M, Solanes F, Perez C, Verdaguer JI, et al
    Mycophenolate Mofetil Therapy in Refractory Inflammatory Eye Disease.
    J Ocul Pharmacol Ther. 2016;32:55-61.
    PubMed     Text format     Abstract available


  116. LINARES-ALBA MA, Gomez-Guajardo MB, Fonzar JF, Brooks DE, et al
    Preformulation Studies of a Liposomal Formulation Containing Sirolimus for the Treatment of Dry Eye Disease.
    J Ocul Pharmacol Ther. 2016;32:11-22.
    PubMed     Text format     Abstract available


  117. KOWALSKI RP, Romanowski EG, Yates KA, Mah FS, et al
    An Independent Evaluation of a Novel Peptide Mimetic, Brilacidin (PMX30063), for Ocular Anti-infective.
    J Ocul Pharmacol Ther. 2016;32:23-7.
    PubMed     Text format     Abstract available


  118. WATANABE A, Tsuzuki A, Arai K, Gekka T, et al
    Efficacy of Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema After Vitrectomy.
    J Ocul Pharmacol Ther. 2016;32:38-43.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ophthalmology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: